Estudio de la efectividad, supervivencia y seguridad de las terapias antirretrovirales de inicio en pacientes VIH+

cilveti-Sáchez, U; Arenere Mendoza, M; Navarro Aznárez, H; Rabaneque Hernández, M. J; Allende-Bandrés, M. A; Mendaza Beltrán, M.
Farm. hosp ; 29(5): 323-330, sept.-oct. 2005. tab, graf
Artículo en Es | IBECS (España) | ID: ibc-045131

Documentos relacionados

  1. Double Negative (DN) [CD3⁺CD4⁻CD8⁻] T cells correlate with disease progression during HIV infection.
  2. Eficacia y seguridad en condiciones clínicas reales del raltegravir en un hospital de referencia del seguro social peruano
  3. Therapeutic Drug Monitoring of HIV Antiretroviral Drugs in Pregnancy: A Narrative Review.
  4. The most popular genes in the human genome.
  5. HIV/AIDS affects blood and blood product use at Groote Schuur Hospital, Cape Town.
  6. Impacto de la Atención Farmacéutica en la adherencia de los pacientes con VIH en el Hospital San Pablo de Coquimbo, Chile
  7. A Novel Simulation-Based Approach for Comparing the Population Against Average Bioequivalence Statistical Test for the Evaluation of Nasal Spray Products on Spray Pattern and Droplet Size Distribution Parameters.
  8. Time to viral load suppression and its associated factors in cohort of patients taking antiretroviral treatment in East Shewa zone, Oromiya, Ethiopia, 2018.
  9. Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design.
  10. Increase in Antiretroviral Therapy Enrollment Among Persons with HIV Infection During the Lusaka HIV Treatment Surge - Lusaka Province, Zambia, January 2018-June 2019.